Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations

BACKGROUND: Nonadherence to antipsychotic treatment increases the likelihood of relapse and progressive symptomatology in patients with schizophrenia. Atypical long-acting injectables, including paliperidone palmitate (PP), may increase adherence and improve symptoms. This study compared and assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Jeffrey P., Icten, Zeynep, Alas, Veronica, Benson, Carmela, Joshi, Kruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648472/
https://www.ncbi.nlm.nih.gov/pubmed/29047368
http://dx.doi.org/10.1186/s12888-017-1507-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648472/
https://www.ncbi.nlm.nih.gov/pubmed/29047368
http://dx.doi.org/10.1186/s12888-017-1507-8

Ejemplares similares